ArticleScientific reports2025
Chemical characterization, antioxidant potential, and cytotoxicity of Bougainvillea spectabilis Willd. flowers cultivated in northern cyprus.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Phytochemical Characterization and Mechanistic Insights into the Cytotoxic Effects of Bougainvillea glabra Bract Extract in Caco-2 Colorectal Adenocarcinoma Cells.Plant foods for human nutrition (Dordrecht, Netherlands) · 2026Article
- Bioactive Fractions fromMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bougainvillea spectabilis Willd. (B. spectabilis), A vibrant ornamental plant native to South America has recently garnered scientific interest due to its diverse phytochemical composition and potential biomedical applications. This study aimed to evaluate the chemical constituents, antioxidant properties, and in vitro cytotoxic effects of ethanolic and aqueous extracts derived from the flowers of B. spectabilis cultivated in Northern Cyprus. Extracts were prepared using Soxhlet extraction, followed by characterization through Fourier transform infrared spectroscopy (FTIR), gas chromatography-mass spectrometry (GC-MS), and nuclear magnetic resonance (NMR) spectroscopies, revealing the presence of various flavonoids, phenolics, and other bioactive compounds. Antioxidant activity was confirmed via 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assays, correlating positively with total phenolic and flavonoid contents. Cytotoxicity was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays on human umbilical vein endothelial cells (HUVECs) at 24, 48, and 72-h intervals. Both extracts exhibited no cytotoxic effects at tested concentrations, maintaining cell viability above 75%. Notably, a pronounced proliferative response was observed, particularly at 48 and 72 h, with ethanolic extract achieving a peak viability of 153%, to reflect metabolic activity more cautiously. These findings suggest that B. spectabilis flower extracts are not only biocompatible but may also possess pro-proliferative properties, underscoring their promise in regenerative medicine and endothelial cell research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.